Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01671774
What this trial is testing

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Gastric AdenocarcinomaCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of Esophagus
Astellas Pharma Global Development, Inc. 29
Not applicableLooking for participantsNCT05714124
What this trial is testing

Liver Embolization Approaches for Tumor Management

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaMetastatic Colon Cancer+4 more
IRCCS San Raffaele 580
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07148427
What this trial is testing

Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06977061
What this trial is testing

Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression

Who this might be right for
Gastric Neoplasm
Queling Liu 30
Testing effectiveness (Phase 2)Study completedNCT00003862
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer

Who this might be right for
Gastric Cancer
Radiation Therapy Oncology Group
Early research (Phase 1)Ended earlyNCT03511222
What this trial is testing

Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

Who this might be right for
Solid TumorHepatocellular CarcinomaGastric Cancer+1 more
Washington University School of Medicine 16
Very early researchActive Not RecruitingNCT05041153
What this trial is testing

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Gastric Cancer AJCC v8+30 more
M.D. Anderson Cancer Center 15
Large-scale testing (Phase 3)Looking for participantsNCT05918094
What this trial is testing

Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Sun Yat-sen University 540
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Not applicableActive Not RecruitingNCT06640153
What this trial is testing

MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer, Gastroesophageal Junction Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Not applicableStudy completedNCT02310230
What this trial is testing

An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy

Who this might be right for
Biliary Tract DiseasesStomach NeoplasmsCarcinoma, Pancreatic Ductal+1 more
Donald Mathews 100
Early research (Phase 1)Study completedNCT04344795
What this trial is testing

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Who this might be right for
Solid TumorColorectal CancerNon Small Cell Lung Cancer+6 more
Tempest Therapeutics 89
Large-scale testing (Phase 3)UnknownNCT05919381
What this trial is testing

Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

Who this might be right for
Adenocarcinoma of Stomach
Changchun GeneScience Pharmaceutical Co., Ltd. 752
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07432295
What this trial is testing

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+3 more
I-Mab Biopharma US Limited 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT04384601
What this trial is testing

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Who this might be right for
Gastric CancerNeoadjuvant Chemotherapy
Ruijin Hospital 246
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667
What this trial is testing

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more
ImmunityBio, Inc. 40
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)UnknownNCT01412294
What this trial is testing

XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer

Who this might be right for
Gastric Cancer
Epidemiological and Clinical Research Information Network 40
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Next Page